Literature DB >> 28554811

The Impact of Prostate Cancer Zonal Origin on Pathological Parameters at Radical Prostatectomy and Subsequent Biochemical Failure.

Patrick E Teloken1, Jian Li2, Clifton G Woods2, Ronald J Cohen3.   

Abstract

PURPOSE: We assessed the impact of prostatic zone tumor origin on pathological prognostic features and subsequent biochemical outcomes after radical prostatectomy.
MATERIALS AND METHODS: A total of 7,051 patients who underwent radical prostatectomy between September 1998 and December 2016 in Western Australia were divided into a high grade group, defined as Gleason sum 4 + 3, 8 and 9 or greater and ISUP (International Society of Urological Pathology) groups 3, 4 and 5, and a low grade group, defined as Gleason sum 6 or less and 3 + 4, and ISUP groups 1 and 2. The t-test and the Pearson chi-square test were used to evaluate differences between transition zone and peripheral/central zone cancer. The Kaplan-Meier method with the log rank test was used to determine differences in biochemical recurrence-free survival at 5 years in patients with high grade disease. Univariate and multivariable Cox proportional hazard regression analyses were performed. Model calibration was determined by the internal validation method.
RESULTS: High grade transition zone cancer was associated with significantly increased prostate specific antigen, tumor volume and incidence of positive surgical margins but a lower incidence of intraductal carcinoma, extraprostatic spread, seminal vesicle invasion, lymph node involvement and biochemical failure after radical prostatectomy. Patients with low grade prostate cancer had excellent biochemical recurrence-free survival regardless of tumor origin. The high grade multivariable model had a c-index of 0.78 and improved predictive accuracy, particularly for high grade transition zone disease.
CONCLUSIONS: Transition zone tumor origin independently and positively impacts biochemical outcomes of high grade prostate cancer. A high grade postoperative prognostic model including transition zone tumor origin as an independent predictor was developed and predictive accuracy was significantly improved in patients with high grade, transition zone disease.
Copyright © 2017 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  neoplasm grading; nomograms; organ specificity; prostate-specific antigen; prostatic neoplasms

Mesh:

Substances:

Year:  2017        PMID: 28554811     DOI: 10.1016/j.juro.2017.05.075

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  5 in total

Review 1.  Prostate zones and cancer: lost in transition?

Authors:  Amin Ali; Alexander Du Feu; Pedro Oliveira; Ananya Choudhury; Robert G Bristow; Esther Baena
Journal:  Nat Rev Urol       Date:  2021-10-19       Impact factor: 14.432

2.  Active surveillance for prostate cancer: comparison between incidental tumors vs. tumors diagnosed at prostate biopsies.

Authors:  Mattia Luca Piccinelli; Stefano Luzzago; Giulia Marvaso; Ekaterina Laukhtina; Noriyoshi Miura; Victor M Schuettfort; Keiichiro Mori; Abdulmajeed Aydh; Matteo Ferro; Francesco A Mistretta; Nicola Fusco; Giuseppe Petralia; Barbara A Jereczek-Fossa; Shahrokh F Shariat; Pierre I Karakiewicz; Ottavio de Cobelli; Gennaro Musi
Journal:  World J Urol       Date:  2021-10-23       Impact factor: 4.226

3.  Association Between Surgical Stress and Biochemical Recurrence After Robotic Radical Prostatectomy.

Authors:  Satoru Meguro; Nobuhiro Haga; Hitomi Imai; Yuki Yoshida; Ruriko Takinami-Honda; Kanako Matsuoka; Seiji Hoshi; Junya Hata; Yuichi Sato; Hidenori Akaihata; Masao Kataoka; Soichiro Ogawa; Yoshiyuki Kojima
Journal:  JSLS       Date:  2021 Jan-Mar       Impact factor: 2.172

4.  Transition zone prostate cancer is associated with better clinical outcomes than peripheral zone cancer.

Authors:  Shun Sato; Takahiro Kimura; Hajime Onuma; Shin Egawa; Hiroyuki Takahashi
Journal:  BJUI Compass       Date:  2020-10-06

5.  Comparison of malignancy and spatial distribution between latent and clinical prostate cancer: an 8-year biopsy study.

Authors:  Liang Zhen; Zhou Zhien; Huang Hanzi; Wu Xingcheng; Xiao Yu; Wang Wenze; Zuo Yuzhi; Chen Yuliang; Zhou Yi; Yan Weigang
Journal:  Eur J Med Res       Date:  2022-09-10       Impact factor: 4.981

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.